ReposiTrak (NYSE:TRAK) Announces Quarterly Earnings Results

ReposiTrak (NYSE:TRAK) issued its quarterly earnings data on Tuesday. The company reported $0.09 earnings per share for the quarter, Zacks reports. The business had revenue of $5.86 million for the quarter. ReposiTrak had a return on equity of 14.53% and a net margin of 30.62%.

Here are the key takeaways from ReposiTrak’s conference call:

• SaaS conversion: ReposiTrak has converted over $7M of one-time revenue to recurring SaaS, increasing recurring revenue from 62% to >98%, which supports higher contribution margins and more predictable revenue.
• Quarterly financials and balance sheet: Q2 revenue rose 7% to $5.9M, operating income increased 34% to $1.8M, GAAP net income was $1.7M (EPS up 13%), and the company holds ≈$28.7M cash with zero bank debt.
• Product & IP investment: The company is investing in AI-driven “Touchless Traceability,” filed two patents (adding to a 9‑patent U.S. portfolio) and claims AI-based detect-and-correct capabilities that it says create a durable competitive moat.
• Capital returns: ReposiTrak repurchased ~80k shares for $1.1M in the quarter, has $6.7M remaining on its buyback authorization, is redeeming preferred shares on a quarterly schedule, and has raised the dividend three times (aiming to return ~50% of operating cash to shareholders).
• Adoption challenges and risks: High supplier data error rates (estimated 50–70%) make traceability complex and slow onboarding, meaning longer sales cycles; AI hype and food inflation could be short‑term headwinds despite expected demand from the looming FDA deadline.

ReposiTrak Stock Down 3.5%

Shares of TRAK traded down $0.32 during trading hours on Thursday, reaching $8.88. 20,901 shares of the company traded hands, compared to its average volume of 83,651. The company’s fifty day moving average price is $11.56 and its two-hundred day moving average price is $14.11. The company has a market capitalization of $162.42 million, a price-to-earnings ratio of 24.00 and a beta of 0.45. ReposiTrak has a 12 month low of $8.87 and a 12 month high of $23.72.

Insider Activity at ReposiTrak

In other news, CEO Randall K. Fields sold 4,500 shares of the firm’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $10.62, for a total transaction of $47,790.00. Following the completion of the transaction, the chief executive officer directly owned 115,000 shares in the company, valued at $1,221,300. This trade represents a 3.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last quarter, insiders sold 110,547 shares of company stock valued at $1,361,233. Insiders own 41.00% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. BNP Paribas Financial Markets lifted its position in shares of ReposiTrak by 63.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock valued at $32,000 after buying an additional 634 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in ReposiTrak by 397.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock worth $71,000 after acquiring an additional 2,892 shares during the period. Walleye Capital LLC purchased a new position in ReposiTrak during the fourth quarter valued at approximately $130,000. Deutsche Bank AG boosted its position in shares of ReposiTrak by 3,132.5% in the fourth quarter. Deutsche Bank AG now owns 10,829 shares of the company’s stock worth $134,000 after purchasing an additional 10,494 shares during the period. Finally, Occudo Quantitative Strategies LP bought a new position in shares of ReposiTrak in the fourth quarter worth approximately $147,000. 27.35% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Weiss Ratings reissued a “hold (c+)” rating on shares of ReposiTrak in a research report on Monday, December 29th. Wall Street Zen lowered ReposiTrak from a “buy” rating to a “hold” rating in a research note on Saturday, January 17th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold”.

About ReposiTrak

ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company’s platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.

At the core of ReposiTrak’s offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.